US Patent Issued to MBQ Pharma on July 7 for "Heterocyclic inhibitors of Rho GTPases for the treatment of disease" (Florida, Puerto Rico Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,960, issued on July 7, was assigned to MBQ Pharma (Canovanas, Puerto Rico).

"Heterocyclic inhibitors of Rho GTPases for the treatment of disease" was invented by John Mccall (Boca Grande, Fla.) and Eric Calderon-Ortiz (Cidra, Puerto Rico).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and methods which may be useful as inhibitors of RhoGTPases for the treatment or prevention of cancer."

The patent was filed on Dec. 21, 2022, under Application No. 18/069,622.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2...